PATENT CLAIM ANALYSIS

Application Number: 15745461
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["548", "255000"]

Abstract:
The disclosure provides process developments and novel routes for the preparation of the NK-1 receptor antagonist, Compound (I) and intermediates in those routes.

Claim (Index 17):
The method of  claim 15 , wherein the Compound (VI) is prepared according to a process comprising combining:\n trimethylsilylacetylene; 4-bromopyridine or a salt thereof; a zinc or copper catalyst; a palladium catalyst; a phosphine, if not already included in the palladium catalyst; a base; and a solvent.

Metadata:
- Claim Count in Document: 108.0
- Percentile: 86.0
- Lexical Diversity: 1.125
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14853883', '14946137', '15355630', '15841828', '13889980']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6735232270331434
- 35 USC 102 Novelty (BERT): 0.4900996956143047
- Combined Prediction Score: 0.6551808738912595
- Mean Citation Score: 216.948504
- Max Citation Score: 220.2003
- Similarity Product: 170.9349070367396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test